Skip to main content
logo
Omkar Pharmachem Limited (BOM:532167)
India flag India · Delayed Price · Currency is INR
16.75
+0.75 (4.69%)
At close: Jul 31, 2026

Omkar Pharmachem Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
4.654.655.45.45.45.4
Revenue Growth
-13.89%-13.89%0%0%0%100.00%
Gross Profit
2.562.563.793.84.013.65
Operating Income
1.581.582.852.783.082.67
Net Income
1.221.222.011.891.981.83
Earnings Per Share
--0.200.190.200.18
EPS Growth
--6.24%-4.40%8.97%-18.02%

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
2.172.171.090.721.332.11
Total Debt
--1.193.036.219.3
Net Cash (Debt)
2.172.17-0.09-2.32-4.89-7.18
Net Cash Growth
------
Net Cash Per Share
---0.01-0.23-0.48-0.71

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
2.282.282.442.962.762.03
Capital Expenditures
---0.04-0.09--0.07
Free Cash Flow
2.282.282.42.862.761.96
Free Cash Flow Growth
-4.63%-4.63%-16.35%3.77%40.77%775.00%

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
55.14%55.14%70.24%70.28%74.28%67.57%
Operating Margin
33.87%33.87%52.76%51.56%57.07%49.41%
Pretax Margin
35.01%35.01%50.00%46.81%48.98%38.98%
Profit Margin
26.19%26.19%37.20%35.02%36.63%33.91%
FCF Margin
49.12%49.12%44.35%53.02%51.09%36.30%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
138.67244.23150.58119.88127.45112.35
P/FCF Ratio
73.95130.24126.3179.1891.37104.96
PS Ratio
36.3263.9756.0241.9846.6938.10